Immutep (IMMP) Change in Cash (2013 - 2017)
Immutep's (IMMP) quarterly Change in Cash came in at -$5348.6 in Q2 2017, up 84.14% YoY from -$2904.6 in Q2 2016, and up 84.14% on a QoQ basis from -$33724.8 in Q2 2016.
Immutep (IMMP) Change in Cash (2013 - 2017) Analysis & Trends
Immutep (IMMP) has 5 years of Change in Cash data on file, last reported at -$5348.6 in Q2 2017.
- Quarterly Change in Cash rose 84.14% year-over-year to -$5348.6 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $35081.9 (up 173.22% YoY) and the FY2025 annual result came in at -$64.8 million, down 349.76% from the prior year.
- Change in Cash climbed to -$5348.6 in Q2 2017, from -$33724.8 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $74432.9 in Q2 2014 to a low of -$88342.7 in Q2 2013.
- A 5-year average of -$10652.2 and a median of -$5348.6 in 2017 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2014 — Change in Cash surged 184.25% — and 2016, when it slumped 12051.34%.
- Tracing IMMP's Change in Cash over 5 years: stood at -$88342.7 in 2013, then soared by 184.25% to $74432.9 in 2014, then sank by 100.37% to -$277.54 in 2015, then tumbled by 12051.34% to -$33724.8 in 2016, then jumped by 84.14% to -$5348.6 in 2017.
- The last three Change in Cash figures came in at -$5348.6 (Q2 2017), -$33724.8 (Q2 2016), and -$277.54 (Q2 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -5,348.62 |
| Jun 30, 2016 | -33,724.81 |
| Jun 30, 2015 | -277.54 |
| Jun 30, 2014 | 74,432.89 |
| Jun 30, 2013 | -88,342.67 |